Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
299.90
-8.89 (-2.88%)
Apr 24, 2025, 9:50 AM EDT - Market open

Madrigal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
6,6226,7304,5685,1791,4491,719
Upgrade
Market Cap Growth
47.33%47.33%-11.79%257.45%-15.74%22.31%
Upgrade
Enterprise Value
6,0115,8514,4525,0751,1511,384
Upgrade
Last Close Price
308.79308.57231.38290.2584.74111.17
Upgrade
PS Ratio
36.4737.36----
Upgrade
PB Ratio
9.018.9211.2726.247.397.17
Upgrade
P/TBV Ratio
9.108.9811.2726.247.397.17
Upgrade
EV/Sales Ratio
33.3732.48----
Upgrade
Debt / Equity Ratio
0.160.160.290.250.000.00
Upgrade
Asset Turnover
0.210.21----
Upgrade
Quick Ratio
5.795.795.353.103.526.10
Upgrade
Current Ratio
6.106.105.383.123.546.13
Upgrade
Return on Equity (ROE)
-80.35%-80.35%-123.98%-150.12%-110.92%-61.61%
Upgrade
Return on Assets (ROA)
-36.98%-36.98%-47.41%-57.71%-54.09%-35.44%
Upgrade
Return on Capital (ROIC)
-44.56%-44.56%-61.78%-82.62%-69.25%-39.26%
Upgrade
Earnings Yield
-6.83%-6.92%-8.18%-5.70%-16.69%-11.76%
Upgrade
FCF Yield
-6.70%-6.79%-7.13%-4.35%-12.71%-9.18%
Upgrade
Buyback Yield / Dilution
-13.83%-13.83%-9.05%-3.64%-7.05%-0.34%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q